Market Moves
Cognito Therapeutics Raises $105M to Bring Alzheimer's Brain Stimulation to Market
The neuromodulation startup closed an oversubscribed Series C led by Morningside Ventures, pushing total funding to $233M as its pivotal Alzheimer's trial nears readout.